Corcept Therapeutics (CORT) PT Lowered to $28 at Truist Securities
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $23.40 +2.36%
Rating Summary:
9 Buy, 6 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 27 | New: 11
Rating Summary:
9 Buy, 6 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 27 | New: 11
Join SI Premium – FREE
Truist Securities analyst Gregory Fraser lowered the price target on Corcept Therapeutics (NASDAQ: CORT) to $28.00 (from $30.00) while maintaining a Hold rating.
You May Also Be Interested In
- BoA cuts Electronic Arts (EA) to neutral following poor 3Q report
- ExxonMobil (XOM) PT Raised to $140 at BofA Securities
- Stryker (SYK) PT Raised to $280 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
